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Changes in the kinetics of muscle contraction in vitamin D-
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Changes in the kinetics of muscle contraction In vitamin D-
depleted rats. Using an in situ rat soleus neuromuscular prepara-
tion, changes in the muscle contraction kinetics in response to
vitamin D depletion were studied. For a single isometric contrac-
tion, the time-to-peak tension (T9) and the time-for-recovery-half-
way-to-resting tension (Ti,2r) were recorded. For a 150 Hz, 300
msec tetanus, the T112 was determined. Animals raised on high-
calcium, high-phosphate, vitamin D-depleted diets showed prolon-
gation of all parameters. Repletion of vitamin D returned T and
Tiir values to normal. Neither dietary calcium deficiency nor
thyroparathyroidectomy produced any prolongation of T or Tizr
values. Therefore, based upon the experimental data, it appears
that vitamin D or one of its metabolites, independent of any effect
on the serum calcium or serum phosphate concentration, is neces-
sary for normal muscle relaxation.
Modifications des cinetiques de Ia contraction musculaire chez
les rats déplétés en vitamine D. Les modifications des cinétiques de
Ia contraction musculaire en réponse a une déplétion en vitamine
D ont été étudiées sur une preparation neuromusculaire de
solCaire. Pour une contraction isométrique unique, le temps de
tension maximale (T9) et Ic temps de demi-rCcuperation de Ia
tension de repos (T112r) ont Cté enregistrés. Le Tii2r a etC deter-
mine pour un tétanos de 300 msec a 150 Hz. Chez les aniniaux
élevés avec une alimentation riche en calcium et en phosphate et
depourvue de vitamine D, un allongement de tous ces paramètres
a Cté observe. L'administration de vitamine D a ramenC T et Ti,2r
a Ia normale. Ni Ic deficit alimentaire en calcium ni Ia thyropara-
thyroidectomie n'ont produit d'allongement de T ou de T112.
Ainsi 11 apparait, de ces rCsultats experimentaux, que Ia vitamine D
ou I'un de ses métabolites, indCpendamment du calcium ou du
phosphore sCriques, est nCcessaire a une relaxation musculaire
normale.
Hemodialysis keeps patients with chronic renal
failure alive, but often these patients develop
musculoskeletal problems. Dialysis patients show
two patterns of muscle weakness: one affecting more
distal muscles and associated with neuropathy and
the other affecting predominantly proximal muscles
[1]. The latter pattern is descriptively identical to
that seen with various forms of osteomalacia [2] and
may respond to therapy with 1 ,25-dihydroxychole-
calciferol [3].
Ample documentation of the association between
osteomalacia and muscle weakness exists [4—9].
Smith and Stern [4] found "unequivocal muscle
weakness" in 20 of 45 patients with osteomalacia of
varying causes. In these patients, strength improved
with vitamin D therapy. The myopathy associated
with osteomalacia is characterized by a patchy, pre-
dominantly proximal involvement, brisk reflexes,
and a waddling gait. The electromyogram shows
abnormalities of the myopathic type without evi-
dence of denervation. Concomitant bone pain makes
evaluation of the extent of muscle weakness difficult.
Muscle enzymes are usually normal but the alkaline
phosphatase is elevated [2]. With the exception of X-
linked hypophosphatemic rickets [101, all forms of
osteomalacia are associated with muscle weakness.
Hypocalcemia is uncommon in osteomalacia, and
the degree of muscle weakness rarely correlates with
the serum calcium [2]. Vitamin D or one of its
metabolites may therefore be necessary for normal
muscle function. These experiments were designed
to study the effect of vitamin D depletion on the
kinetics of muscle contraction.
Methods
Male Sprague-Dawley rats were raised from the
weaning stage for 65 to 74 days on the various regi-
mens indicated in Table 1. Special test diets were
purchased from Teklad Laboratories. These were:
TD 74597 with 1.5% calcium, 1.5% phosphorus, and
vitamin D; TD 73446 with 1.5% calcium, 1.5% phos-
phorus, and no vitamin D; TD 76028 with 0.05%
calcium, vitamin D, and no phosphorus added to
casein hydrolysate; and TD 73445 with 0.05% cal-
cium and no phosphorus added to casein hydrolysate
and no vitamin D. The animal quarters were free of
ultraviolet radiation.
Animals in group 2 were thyroparathyroidectom-
ized by cautery 10 days before the experiments. Only
those animals of this group with serum calcium con-
centrations less than 7.0 mgIlOO ml were included in
the final data. Animals in group 5 received 1 mg of
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Group
no. Description
I Normal diet (Purina Rat Chow)
2 Normal diet, parathyroidectomy performed two weeks
prior to experiment
3 High-calcium (1.5%), high-phosphate (1.5%), with vita-
min D diet
4 High-calcium (1.5%), high-phosphate (1.5%), without
vitamin D diet
5 High-calcium (1.5%), high-phosphate (1.5%), without
vitamin D diet but animals were supplemented with
vitamin D
6 Low-calcium (0.05%), low-phosphate, with vitamin D
diet
7 Low-calcium (0.05%), low-phosphate, with vitamin D
diet, and with calcium gluconate in drinking water
8 Low-calcium (0.05%), low-phosphate, without vitamin
D diet, and with calcium gluconate in drinking water
crystalline cholecalciferol dissolved in peanut oil by
tube feeding 6 to 8 days before the experiments.
Groups 7 and 8 were given drinking water containing
1.5% calcium gluconate.
For all animal groups the following dissection was
made: The left sciatic nerve was sectioned at the hip,
the popliteal fossa was dissected and all nerves
except those innervating the soleus, and gastrocne-
mius muscles were cut. The leg was rigidly mounted
in a myograph with appropriately placed steel pins.
The gastrocnemius tendon was cut just above the
calcaneus, and the soleus tendon with a remnant of
the calcaneal spur was attached to a strain guage.
Thus, only the isometric tension developed by the
soleus muscle was measured. The exposed tissues
were covered with liquid paraffin.
The stimuli were rectangular pulses of 0.1 msec
duration and were delivered via an isolation unit by
bipolar platinum electrodes placed on the sciatic
nerve. The threshold voltage was determined, and
then the voltage was set approximately four times
that voltage. The frequency of stimulation was 0.1
Hz.
The profiles of isometric contractions, developed
in response to single stimuli applied to the nerve,
were displayed on an oscilloscope and photo-
graphed. Next, a 150-Hz train for 300 msec was
delivered to the nerve. The oscilloscope display was
triggered by the end of the train, enabling the record-
ing of the relaxation of the tetanic contraction of the
soleus muscle.
For the single contraction, the time-to-peak ten-
sion (Tn) and the time-for-recovery-halfway-to-the-
baseline (Tiitr) were recorded (Fig. 1). For the teta-
nus, the T112r was determined (Fig. 1).
At the conclusion of each experiment, blood was
FIg. 1. Scheme of the various contractile parameters measured.
Upper tracing shows the time-to-peak contractile tension (Tn) and
the time-to-half-relaxation-from-peak tension (Tjj2r) of a single
maximal muscle contraction. Lower tracing shows the time-to-
half-relaxation-from-peak tension (T112r) of a maximal, tetanic
muscle response.
collected from the right femoral artery. Total serum
calcium was determined by fluorometry and serum
phosphate by a microcolorometric method.
Results
Experimental results are summarized in Tables 2
and 3. The striking finding is the prolongation of Tijtr
for both the single and the tetanic contractions in
vitamin D-depleted animals on a high-calcium, high-
phosphorus diet (group 4). The time-to-peak tension
(T0) also appears to be lengthened. As is evident
from Figure 2, the shape of the tension vs. time curve
for the single contraction is altered in group 4' ani-
mals. Repletion with vitamin D (group 5) restored all
parameters to normal. In animals which were vita-
min D-depleted but raised on a high-calcium, low-
phosphorus diet (group 8), T112 for the tetanus is not
significantly increased.
In animals made hypocalcemic by dietary deficien-
cy of calcium (group 6), there was no significant
change in any of the parameters tested. Curiously,
the animals made hypocalcemic by thyroparathyro-
idectomy (group 2) showed a tendency toward short-
Table 1. Regimens for all groups of rats studied Single contraction
Tetanus (150 Hz)
PT
p peak tension
= time to peak
T1 r time to recovery
\1avasel
me
300 2msec —..
t
Display
on
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Table 2. Results of contractile responses of all groups studied
Single contraction Tetanic contraction
Time to '/z Time to /2
Time to peak (Tn) decay (T112r) decay (T112r)
Group N msec P msec P msec P
I (normals) 11 17.1 0.5 — 14,8 0.2 — 34.9 1.0 —
2 (parathyroidectomized) 9 15.4 0.7 <0.1 13.6 0.5 <0.05 31.6 1.5 <0.1
3 (high-Ca, high-P) 8 17.0 0.8 NS 14.6 1.0 NS 31.2 2.7 NS
4 (high-Ca, high-P. no vit. D) 17 18.7 0.6 <0.1 20.7 0.8 <0.001 40.7 1.5 <0.02
5 (high-Ca, high-P, no vit. D 8 16.6 0.7 NS 15.6 0.8 NS 32.0 2.0 NS
diet but vit, D supplements)
6 (low-Ca, low-P) 5 17.5 0.8 NS 15.3 0.8 NS 34.0 3.3 NS
7 (high-Ca, low-P) 11 16.9 1.0 NS 14.4 0.8 NS 33.0 2.0 NS
8 (high-Ca, low-P, no vit. D) 8 17.2 0.6 NS 19.2 1.2 <0.001 32.8 1.9 NS
a N = number of animals.
Group N
Serum
calcium
mg/lOO ml
Serum
phosphate
mg/lOO ml
Animal
weight
g
I (normals) 11 9.4 0.1 7.0 0.6 373 21
2 (parathyroidectomized) 9 6.0 0.2 12.3 0.7 331 26
3 (high-Ca, high-P) 8 9.5 0.2 6.5 0.7 344 10
4 (high-Ca, high-P, no vit.
D) 17 4.6 0.2 9.1 0.4 243 11
5 (high-Ca, high-P, no vit.
D diet but vit. D
supplements) 8 9.4 0.2 8.8 1.3 323 13
6 (low-Ca, low-P) 5 5.1 0.5 7.9 0.5 210 15
7 (high-Ca, low-P) Il 9.7 0.3 6.9 0.4 255 24
8 (high-Ca, low-P, no vit.
D) 8 7.4 0.2 3.6 0.1 217 7
a N = number of animals.
ening of all of the time parameters measured. It
therefore appears that the changes in Tl/2r are inde-
pendent Of the serum calcium concentration.
Neither dietary depletion of phosphate (group 7)
nor supplementation (group 3) produced any signifi-
cant change in any of the time parameters measured.
As expected, parathyroidectomy increased the ser-
um phosphate but, as noted above, certainly did not
increase the Tiizr for either the single contraction or
the tetanus. The increase in Tl/2r'5 in group 4 are
therefore not the result of changes in the serum
phosphate per se. The tracings obtained with groups
of animals on diets different from group 4 are shown
in Figure 3.
The rats used in these experiments were growing
animals. It is therefore not surprising that there were
considerable differences in body weights in animals
of the same age. The smallest animals were those
raised on diets low in both calcium and phosphorus.
Several of these animals died of spontaneous frac-
tures of the vertebral column. Phosphorus depletion
and vitamin D depletion, both separately and togeth-
er, produced growth retardation. Because the ani-
mals in the various groups were of such different
sizes, comparison of single tensions and tetanic ten-
sions was not possible.
Discussion
These studies show that, in the rat, depletion of
vitamin D will prolong the relaxation phase of a
muscle contraction. The effect is independent of the
serum calcium concentration, since both thyropara-
thyroidectomy and dietary depletion of calcium
cause hypocalcemia but do not prolong the Tj/2r.
The effect is also independent of the phosphate
concentration in the serum. It is possible, however,
that muscle phosphate transport is altered by vitamin
D depletion. Since phosphate depletion in man will
produce myopathy [11], our results might be
explained by a decrease in intracellular phosphate in
the vitamin D-depleted animals. If that were the total
Table 3. Serum calcium and serum phosphate concentrations and
body weights for all groups studied
Single contraction Tetanus
T, l5msec; T-r' l4msec
Control
Group 4
(Hi'Ca. Hi-P. no vit. Dl
Fig. 2. Upper tracings: Control muscle tensions for single and
tetanic responses in rats fed normal diet. Lower tracings: Muscle
tensions for single and tetanic responses in rats fed a high-
calcium, high-phosphate, and no vitamin D diet.
T, 21 msec; Tir 22 msec Tr53 msec
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explanation for our results, one would anticipate that
the hypophosphatemic animals in group 8 would be
more affected than those in group 4. In fact, in one of
the parameters we measured, the Tiir for the tetanus
was normal in group 8.
Hemodialysis patients develop a form of muscle
dysfunction which is descriptively identical to that
seen in various forms of osteomalacia [21. It would
be difficult to ascribe their myopathy to a reduction
in intracellular phosphate since, in fact, it is normal
or increased [12].
The difference between group 4 and group 8 ani-
mals warrants further comment. The T112r for the
tetanus was significantly prolonged in group 4 but not
group 8. There was also a tendency for the twitch
parameters to be shorter in group 8 than group 4,
although both were significantly increased over the
control and were not significantly different from each
other. If 1 ,25-dihydroxycholecalciferol (1 ,25-DHCC)
is the form of vitamin D which is necessary for
normal muscle function, these results could be
explained. Low phosphate stimulates and high phos-
phate inhibits the 1-hydroxylation step in the kidney
[13, 14]. Whatever small amount of vitamin D
remained in the group 8 animals, it may have been
pushed toward 1,25-DHCC by the low phosphate,
whereas in group 4 animals, the reaction would have
been inhibited.
Muscle, in addition to bone, intestine, and kidney,
appears to be a target organ for vitamin D metabo-
lites. Several reasons exist for postulating a direct
effect of vitamin D on muscle. Tritiated vitamin D
localizes to skeletal muscle membranes [15]. If cor-
rections are made for non-cellular elements, physio-
logical doses of vitamin D are found in high concen-
trations in skeletal muscle [161. The uptake of
phosphate and leucine by muscle from vitamin D-
depleted rats is augmented by 25-hydroxycholecalci-
ferol [17]. Sarcoplasmic reticulum isolated from the
psoas muscle of rabbits fed a vitamin D deficient diet
shows a decreased ability to bind calcium, as com-
pared to that isolated from animals receiving a nor-
mal diet[18].
The release of calcium from the sarcoplasmic
reticulum (SR) in response to an action potential
initiates muscle contraction, and active sequestration
of calcium by the SR terminates contraction. Any-
thing which disturbs the release or sequestration of
calcium by the SR should alter the kinetics of con-
traction. In both skeletal [19] and cardiac muscle
[20], caffeine lengthens the time course of an isomet-
ric contraction. Treatment of isolated SR with caf-
feine causes the release of calcium and the decreased
binding of added calcium [211. Thus, depletion of
vitamin D or one of its metabolites appears to induce
a caffeine-like effect on muscle.
The action of vitamin D on the SR is different from
that of caffeine in that the latter is effective immedi-
ately. In studies on SR isolated from the muscle of
uremic rabbits, Matthews et al [22] showed that
administration of 1 ,25-DHCC to the animals for five
days prior to sacrifice improved the ability of the SR
to concentrate and store calcium. In muscle from
untreated animals, 1,25-DHCC was without effect
when added to the SR preparation. Thus, a period of
time is needed in vivo for 1,25-DHCC to have an
effect.
Which metabolite of vitamin D is most important
in muscle function remains unanswered. The data of
Matthews et al [22] indicate that 1,25-DHCC will
reverse the defect in sequestration of calcium by the
sarcoplasmic reticulum induced by experimental ure-
mia. On the other hand, Birge and Haddad [17]
showed that addition of a physiologic concentration
of 25-hydroxycholecalciferol (25-HCC) to an epitro-
chlear muscle culture stimulates the incorporation of
leucine into protein and raises the ATP content of the
muscle. Supraphysiologic doses of 1 ,25-DHCC are
without effect. A receptor protein in muscle with a
greater affinity for 25-HCC than l,25-DHCC has
been described [23].
Further studies are therefore necessary to deter-
mine which of the metabolites is most effective in
reversing the myopathy of vitamin D depletion.
When that metabolite is identified, it may be useful in
treating dialysis patients with muscle weakness.
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